| RS2146359668 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146360319 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146360458 |
SMARCA4
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146362916 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146362992 |
CBS
|
Health Risk |
Likely pathogenic |
Homocystinuria, Classic homocystinuria |
| RS2146363405 |
KANSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Koolen-de Vries syndrome |
| RS2146366969 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146368271 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young type 1 |
| RS2146370110 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146373286 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 42, Spinocerebellar ataxia type 42 |
| RS2146373452 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146373508 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146374989 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375012 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375064 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375213 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375350 |
HNF4A
|
Health Risk |
Likely pathogenic |
— |
| RS2146375487 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2146375662 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS2146375818 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375836 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375885 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375951 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146375964 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146376221 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146377060 |
TUBB1
|
Health Risk |
Pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146377702 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146379302 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146379356 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146379725 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146380786 |
PRPF31;PRPF31-AS1;TFPT
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa |
| RS2146381019 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146381604 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146383463 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146383561 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146383573 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146385603 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146385757 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146387904 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146387963 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146388096 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS2146389344 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146392500 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146392573 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146392668 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146392811 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146392848 |
MYH9
|
Health Risk |
Pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146392922 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146393019 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146393119 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146393245 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146393282 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146393621 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146393861 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146393934 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146394096 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146394271 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146394968 |
CBS
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2146395543 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146406554 |
NOVA2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities, Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities |
| RS2146406674 |
NOVA2
|
Health Risk |
Pathogenic |
— |
| RS2146406775 |
NOVA2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2146407735 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146408539 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146409388 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146409471 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146409568 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS2146409888 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146409966 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146410280 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146410489 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146410761 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146411947 |
HNF4A
|
Health Risk |
Pathogenic |
— |
| RS2146412136 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 1, Monogenic diabetes |
| RS2146412304 |
CLDN14
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS2146413207 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146413215 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2146413305 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146413337 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146413440 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146413580 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146413624 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146413726 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146413876 |
CDC45
|
Health Risk |
Pathogenic |
— |
| RS2146413970 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146414477 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146416371 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
SMARCA4-related BAFopathy, Intellectual disability |
| RS2146417182 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146417384 |
SMARCA4
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146417554 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2146417581 |
HNF4A
|
Health Risk |
Pathogenic |
— |
| RS2146418475 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2146418544 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146418683 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146418714 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146418999 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 11, Retinal dystrophy |
| RS2146419846 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146420160 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinal dystrophy |
| RS2146420442 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2146420461 |
PRPF31
|
Health Risk |
Pathogenic |
— |